May Hill Capital’s AstraZeneca AZN Stock Holding History

May Hill Capital’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$481K	Sell	2,535 -162	-6%	-$30.5K	0.1%	133
2026 Q1	$532K	Sell	2,697 -3,297	-55%	-$636K	0.13%	105
2025 Q4	$1.1M	Buy	5,994 +1,080	+22%	+$189K	0.3%	58
2025 Q3	$754K	Buy	4,914 +317	+7%	+$48K	0.22%	73
2025 Q2	$642K	Buy	4,597 +324	+8%	+$45.4K	0.21%	78
2025 Q1	$628K	Buy	4,273 +2,010	+89%	+$291K	0.24%	65
2024 Q4	$296K	Buy	+2,263	New	+$317K	0.11%	116

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

May Hill Capital's AZN Position: Q2 2026 in Review

May Hill Capital reduced its AstraZeneca (AZN) stake by 6% in Q2 2026, selling an estimated $30.5K and leaving 2,535 shares worth $481K. The position accounts for 0.1% of the portfolio, ranked #133.

May Hill Capital first reported a position in AZN in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.1M in Q4 2025. 1,504 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

May Hill Capital held 2,535 shares of AstraZeneca worth $481K as of Q2 2026.
May Hill Capital sold 162 AstraZeneca shares in Q2 2026, an estimated $30.5K.
AstraZeneca made up 0.1% of May Hill Capital's portfolio in Q2 2026, its #133 holding.
May Hill Capital first reported a position in AstraZeneca in Q4 2024 and has held it in 7 quarters since.
May Hill Capital's AstraZeneca position peaked at $1.1M in Q4 2025.
1,504 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on May Hill Capital's 13F filing for Q2 2026, filed 7 Aug 2026.